NeuroMetrix Inc. (NURO)
3.98
-0.07 (-1.73%)
At close: Jan 14, 2025, 3:58 PM
4.01
0.88%
Pre-market Jan 15, 2025, 09:28 AM EST
undefined% (undefined)
| Bid | 3.95 |
| Market Cap | 8.12M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -4.51 |
| PE Ratio (ttm) | -0.88 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 4.01 |
| Volume | 31,152 |
| Avg. Volume (20D) | 21,290 |
| Open | 4.10 |
| Previous Close | 4.05 |
| Day's Range | 3.95 - 4.10 |
| 52-Week Range | 2.66 - 4.73 |
| Beta | undefined |
About NURO
NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for s...
Industry Medical - Devices
Sector Healthcare
IPO Date Jul 22, 2004
Employees 26
Stock Exchange NASDAQ
Ticker Symbol NURO
Website https://www.neurometrix.com
